In an interview with Carmen Aristegui, Arias Ortiz from the Institute of Biotechnology of the National Autonomous University of Mexico (UNAM), talks about the context in which he considers the vaccination plan will begin: a rebound in cases after the December meetings.
He assures that even though the vaccination campaign begins, the effects on the population will become visible when 60% have been immunized.